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META-ANALYSIS: OBSTRUCTIVE SLEEP APNEA AND OCULAR DISEASES 
GIANNA DINGILLO 
ABSTRACT 
PURPOSE: Previous studies have reported an increased prevalence of ocular diseases in 
patients with obstructive sleep apnea. The purpose of this study was to examine the link 
between such ocular diseases as diabetic retinopathy, diabetic macular edema, retinal 
vein occlusion, central serous chorioretinopathy, age-related macular degeneration, non-
arteritic anterior ischemic optic neuropathy, and glaucoma. 
METHODS: This meta-analysis was conducted through a search using PubMed, Web of 
Science, Scopus and EMBASE. We identified both retrospective and prospective studies.  
RESULTS: The final meta-analysis looked at 30 studies and 7 ocular diseases. The data 
showed a high prevalence of obstructive sleep apnea for diabetic retinopathy and diabetic 
macular edema patients. Data for glaucoma and non-arteritic anterior ischemic optic 
neuropathy patients did not show a statistical increase.  There was not enough data for 
retinal vein occlusion, central serous chorioretinopathy and age-related macular 
degeneration to calculate statistical significance.  
CONCLUSION: These data suggests that patient populations with diabetic retinopathy 
and macular edema show increased rates of obstructive sleep apnea. Data suggest that 
hypoxia is an important part of the pathophysiology of diabetic retinopathy and diabetic 
macular edema. Because obstructive sleep apnea has been shown to affect the 
progression of the ocular diseases included in this study, ophthalmologists should screen 
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Obstructive sleep apnea (OSA) is a disease characterized by blockage of the airways 
during sleep that may last for as little as ten seconds but may expand for up to ten 
minutes at a time (Medline Plus 2019a). Though the critical line indicating the brain’s 
message to the body to breath are different for each person, the resulting hypoxia and 
hypercapnia can cause a myriad of problems on various organ systems (Mijacika and 
Dujic 2016).  
 
Obstructive Sleep Apnea  
OSA is described as a breathing disorder due to blockage or narrowing of the airways 
during sleep (Medline Plus 2019a) that affects 9%-38% of the general population 
(Senaratna 2017). This may cause a myriad of symptoms including, but not limited to, 
disruptive snoring, daytime sleepiness, decrease in attention, concentration, or memory, 
dry mouth or headaches, sexual dysfunction, decreased libido, frequent nightly urination, 
depression, anxiety and decreased motor skills (National Heart, Lung and Blood Institute 
2018). 
 
Diagnosis of Obstructive Sleep Apnea  
To diagnose OSA, a physician may employ either in-clinic or at-home techniques to 
determine presence and severity of OSA. The gold standard for diagnosing OSA is 
polysomnography (PSG), a method which requires spending a night at the hospital while 




blood oxygen levels (Mayo Clinic 2011b). Two very commonly used measurements for 
determining severity of OSA are the oxygen desaturation index (ODI) and the apnea 
hypopnea index (AHI). ODI is measured using an oximeter and it is a measurement of the 
number of times the oxygen level in blood desaturates during sleep (Itamar Medical 
Dictionary 2019). Desaturation is defined as the oxygen level dropping at least 4% or 
more during sleep (Itamar Medical Dictionary 2019). The Apnea Hypopnea Index 
calculates the number of complete cessations and partial obstructions of breathing, apneas 
and hypopneas respectively, per hour of sleep (Itamar Medical Dictionary 2019). Severity 
of sleep apnea per the AHI is as follows: normal (AHI < 5), Mild (AHI ≥ 5, but <15), 
Moderate (AHI ≥ 15, but <30), Severe (AHI ≥ 30) (Harvard University Division of Sleep 
2011). Because physically monitoring patients can be costly and time consuming, two 
widely recognized surveys used to diagnose sleep apnea have been developed: The Berlin 
Questionnaire (BQ) and the Epworth Sleepiness Scale (ESS). BQ asks questions about 
BMI, hypertension, daytime sleepiness, and snoring as well as consulting family 
members that may be able to answer more accurately for the patient (Thurtell et al. 2011). 
The Epworth Sleepiness Scale is similar to the BQ in that it can be used to assess patients 
that are suspected to have OSA, however this questionnaire differs in that it is targeted 
towards assessing daytime sleepiness as shown in Figure 1 (Johns 1991). It should be 
noted that patients who are classified as high-risk by this test should be diagnosed via 





Figure 1: Epworth Sleepiness Scale Assessment Form: Obstructive Sleep Apnea form 
used to assess patients with chronic daytime sleepiness. In each category listed on the 
left, patients may select: (0) would ever doze, (1) slight chance of dozing, (2) moderate 
chance of dozing, or (3) high chance of dozing. Scorers add up values for each section. 
Total scores range from 0-24. Scores adding up to 10 or greater indicate the presence of 
sleep apnea (Johns 1997). 
 
 
Diabetic Retinopathy  
Diabetic Retinopathy (DR) has emerged as a global epidemic and have caused visual loss 
in millions of patients worldwide. Within the U.S. alone, it is the leading cause of 
blindness in individuals aged 20 to 64 (Crawford et al. 2009). Per the Indian Journal of 
Ophthalmology, the number of individuals suffering from DR is expected to increase 




from 37.3 million to 56.3 million by 2030 (Zheng et al. 2012). Although DR is becoming 
more prevalent, little is known about its pathogenesis nor is there a standardized 
treatment. DR primarily results from chronically elevated plasma glucose, otherwise 
known as Type 2 Diabetes Mellitus (T2DM), in which the high blood sugar causes 
damage to blood vessels within the eye by inducing the vessels to swell, leak or close off 
completely (Boyd and Vemulakonda 2018). There are two stages of DR: non-
proliferating diabetic retinopathy (NPDR), and proliferating diabetic retinopathy (PDR). 
In NPDR, the early stage, blood vessels can either leak and promote macular edema or 
close off and cause macular ischemia and low perfusion of the eye (Boyd and 
Vemulakonda 2018). In PDR, the advanced stage, the endothelial and smooth muscle 
cells of blood vessels begin to proliferate and undergo angiogenesis (neovascularization), 
where these new vessels are prone to hemorrhage (Boyd and Vemulakonda 2018). In this 
stage, the retina can become detached, due to excess scarring, leading to vision-loss and 
potential blindness (Boyd and Vemulakonda 2018).  
 
 Diabetic Macular Edema  
Physiologically, increased levels of plasma glucose cause several problems in the body, 
one of them being the ability to make retinal capillaries incapable of gas exchange 
(Crawford et al. 2009). This lack of capillary function causes hypoxia and leads to 
ischemia within the retina (Adair and Montani 2010). Hypoxic conditions within the 
retina have been shown to induce two main effects of DR: intra-retinal angiogenesis and 




angiogenesis by increasing production of Vascular Endothelial Growth Factor (VEGF-
A), leading to a proliferative endothelial wall that can form new blood vessels (Shortt et 
al. 2004). In the case of the retina, the blood vessels formed are often misshapen and lead 
to hemorrhage and vision loss (Shortt et al. 2004). Secondly, hypoxia leads to profound 
arteriolar dilation which has the effect of increasing the pressure on the venous and 
capillary walls (Gardner et al. 2002). As explained by Starling’s Law and the Law of 
Laplace, the increased pressure on the walls of veins and capillaries has three main 
effects that lead to macular edema: (1) leaky tight junctions, (2) vessel dilation and (3) 
elongation of vessels which all cause the transudation of fluid into the retinal interstitium 
(Gardner et al. 2002). This eventually leads to a mismatch between metabolism and blood 
flow within the retina and therefore, vision loss (Gardner et al. 2002). When fluid builds 









Figure 2: Diabetic retinopathy and potential treatments: The preliminary stage of DR 
(top left), NPDR, is generally not treated. However, this stage may progress to PDR (top 
right) or may develop hemorrhages and cause diabetic macular edema (bottom center). 
PDR (top right) shows signs of neovascularization and may be treated with lasers, anti-
VEGF injections or vitrectomy. Additionally, this stage may also develop diabetic 
macular edema if edema is present. DME (bottom center) may be treated by anti-VEGF 
injections, corticosteroids or vitrectomy (Kubota Pharmaceutical 2019). 
 
Diabetic Complications and Sleep Apnea 
While OSA is a relatively common breathing disorder, the prevalence is significantly 
increased in patients with diabetes, especially in T2DM. Compiled data released in a 
2012 meta-analysis shows the link between patients with T2DM with OSA to be 71% as 
diagnosed by full polysomnography (Pamidi and Tasali 2012). The underlying 
phenomena affecting patients with DR and DME is related to the problems caused by 
OSA. Firstly, it has been shown that elevated blood concentration of VEGF is observed 




age of 50 (Zhang et al. 2014). This increase is associated with the hypoxia involved in the 
cessation of breathing during sleep (Kähler et al. 2003). With the increase in hypoxia, 
VEGF and neovascularization, diabetic complications such as retinopathy or edema are 
hypothesized to worsen. 
 
Retinal Vein Occlusion  
Retinal Vein Occlusion (RVO) is the second most common cause of vision loss, affecting 
nearly 16.4 million people worldwide (Laouri et al.). RVO is a blockage of one of the 
veins leaving the retina (Medline Plus 2019b). RVO can be divided into central (CRVO) 
or branch (BRVO) retinal vein occlusions depending on the location of the blockage 
(Medline Plus 2019b). Within the CRVO distinction, RVO can be further classified into 
ischemic or non-ischemic depending on blood flow (Medline Plus 2019b). Possible 
causes of RVO include hypertension and diseases of the vein wall (Laouri et al. 2011). 
While there is no way to reverse, or remove the blockage, there are treatments available 
aimed at regaining vision in the affected eye (Medline Plus 2019b). Two common 
treatment methods involve the use of focal laser treatment to prevent edema and 





Figure 3: Central Retinal Vein Occlusion: (A) Fundus photo showing hemorrhages 
(white arrows), cotton-wool spots (black arrows), edema (yellow arrows) (B) horizontal 
optical-coherence scan showing retinal thickening (white arrows) and edema (yellow 
arrows) (adapted from Wong 2010). 
 
Retinal Vein Occlusion and Obstructive Sleep Apnea 
Known risk factors include atherosclerosis, diabetes, hypertension and other ocular 
conditions such as glaucoma, macular edema or vitreous hemorrhage (Medline Plus 
2019b). However, more recently the correlation between RVO and OSA has been 
researched. Studies show that there is a higher than expected prevalence of OSA in 
patients with RVO (Glacet-Bernard et al. 2010). While the two diseases may develop due 
to similar risk factors such as BMI, smoking status or hypertension, there have also been 
two proposed mechanisms showing how OSA might act as a trigger for RVO (Glacet-
Bernard et al. 2010). This was initially researched due to the discovery that most RVO 
occurs upon waking. The first mechanism proposes that hypoxia, hypercapnia and 
activation of the sympathetic nervous system induced by the disordered breathing 




compressing the retinal vein (Kwon et al. 2016). The second mechanism proposes that 
the intermittent hypoxia caused by OSA produces reactive oxygen species and 
inflammatory cytokines (interleukin-6 and tumor necrosis factor-α) (Kwon et al. 2016). 
These then cause expression of tissue factors of endothelial cells to trigger the extrinsic 
coagulation pathways and platelet aggregation (Kwon et al. 2016).  
 
Central Serous Chorioretinopathy  
Central Serous Chorioretinopathy (CSCR) is a condition in which fluid builds up under 
the retina, and may cause detachment (Bakri et al. 2016). Central Serous 
Chorioretinopathy affects men and women, however it most commonly affects males 
between the ages of 30-50 years old at an annual incidence rate of 27% for males and 
15% for females (Tsai et al. 2013). The pathology of CSCR is not fully understood, 
however CSCR may develop in response to use of corticosteroids or high cortisol 
production in people with “type A personalities” (Bakri et al. 2016). Treatments for 
CSCR include thermal laser treatment, photodynamic cold laser therapy, injection, and 
oral medication, however often times there is no need for treatment as the condition may 
be self-limiting and reverse on its own (Bakri et al. 2016). 
 
Central Serous Chorioretinopathy and Obstructive Sleep Apnea 
Patients with OSA have increased levels of epinephrine and norepinephrine due to the 




experienced during sleep (Leveque et al. 2007). Though the association is unclear, there 
seems to be a positive feedback loop functioning on the hypothalamus-pituitary-adrenal 
axis responding to increased circulating catecholamines then causing an increase in 
cortisol secretion and corticosteroid production (Leveque et al. 2007). With increased 
corticosteroids present in the bloodstream, they may influence the choroid causing fluid 
to build up and cause vision loss.  
 
Age-Related Macular Degeneration  
Per the National Eye Institute, Age-Related Macular Degeneration (AMD) is a leading 
cause of vision loss in the U.S. It currently affects 2.07 million Americans and is 
projected to double to 5.44 million in the next 30 years (National Eye Institute 2018).  
AMD is usually triggered by a central lesion on the retina and is associated in patients, 
primarily over 75 years old (Young 1987). It is noted as an advanced stage of retinal 
pigment epithelium (RPE) deterioration that naturally occurs as the eye ages (Young 
1987). A common treatment used for slowing down deterioration of the eye is intravitreal 
injections of Bevacizumab (Avastin), an anti-angiogenic drug (Gavin Herbert Eye 
Institute 2018). In wet AMD, it has been implicated that hypoxia promotes increased 
VEGF levels that lead to neovascularization which cause leaking, fluid build-up and poor 
vision (Ng and Adamis 2005). By targeting the increased levels of VEGF, clinicians can 
slow or stabilize vision loss by decreasing the level of neovascularization taking place 
(Ng and Adamis 2005). However, intravitreal injections affect the quality of life in many 




Additionally, they do not tend to improve the problem, but slow down progression of 
deterioration.  
Age-Related Macular Degeneration and Obstructive Sleep Apnea 
OSA may contribute to non-response of AMD patients to anti- VEGF injections (West et 
al. 2018). This may occur because of the common pathogenesis between OSA and AMD 
and their relationship to angiogenesis and increased vascular permeability (Nesmith et al. 
2014). This may be related to the fact that both OSA and AMD upregulate VEGF 
production and therefore, hinder anti-VEGF therapy (Schaal et al. 2016). Additionally, it 
has been shown that Continuous Positive Air Pressure (CPAP) therapy may promote 
positive responses to anti-VEGF treatment by decreasing macular volume and sub-retinal 
fluid and a decreased need for anti-VEGF injections (Schaal et al. 2016). As a result, 
because OSA is commonly undiagnosed and may lead to further macular degeneration if 
it is left untreated, it is beneficial to screen and treat AMD patients for OSA. 
 
Non-Arteritic Anterior Ischemic Optic Neuropathy  
Non-Arteritic Anterior Ischemic Optic Neuropathy (NAION) causes painless vision loss 
to one or both eyes due to loss of blood flow to the optic nerve which may occur upon 
waking (Brigham and Women’s Hospital 2019). In the United States, the incidence of 
NAION is 2.3-10.2/100,000 (Lee et al. 2011). Additionally, this condition should be 
distinguished from the less common Arteritic Ischemic Optic Neuropathy (AAION) 




to the blood vessels (Rodriguez et al. 2018). NAION is thought to be multifactorial in 
nature with a combination of causes ranging from vascular dysfunction, crowded optic 
nerve, hypertension, hypercholesterolemia, diabetes and OSA (West et al. 2018). 
Currently, no treatment for NAION exists and pathophysiology is not well understood 
(Atkins et al. 2010).  
 
Non-Arteritic Anterior Ischemic Optic Neuropathy and Obstructive Sleep Apnea 
Current hypotheses aiming to describe the relationship between NAION theorize that 
frequent apnea and hypopnea cause irregular blood flow autoregulation to the optic nerve 
head and lead to ischemia (Arda et al. 2013). Additionally, it has been hypothesized that 
frequent hypoxia may also lead to increased intracranial pressure and direct optic nerve 
head damage (Arda et al. 2013). For this reason, it may prove beneficial to screen patients 
for OSA by polysomnography.   
 
Glaucoma 
Glaucoma is a disease that affects nearly 3 million Americans (CDC 2018). Glaucoma is 
caused by excess pressure on the optic nerve, resulting in nerve damage and potential 
blindness (Boyd and McKinney 2018a). The most common form of glaucoma is Open 
Angle Glaucoma (OAG), which can take two forms: Primary Open Angle Glaucoma 
(POAG) and Normal Tension Glaucoma (NTG). In OAG, the drainage angle is larger 




nerve (Boyd and McKinney 2018d). The major difference between POAG and NTG is 
that with POAG, intraocular pressure (IOP) is greater than 21 and with NTG, IOP is 
below 21 (Boyd and McKinney 2018c). There is no cure for glaucoma, however 
treatment options include pressure-lowering eye drops and laser treatment to help 
aqueous humor drain from the eye in a more effective way (Boyd and McKinney 2018b). 
Glaucoma and Obstructive Sleep Apnea 
While it has been shown that there may be a relationship between glaucoma and OSA, 
the results are controversial. Additionally, there is little known about the interaction 
between glaucoma and OSA even though some studies have established a statistically 
significant correlation. Therefore, more studies should be done to establish a potential 





Figure 4: Normal vs. Open Angle Glaucoma: Eyes of normal subjects (left) show an 
appropriate flow of aqueous humor. Patients with glaucoma, however, show blocked 
trabecular meshwork that causes increased pressure in the eye (right). Increased pressure 
can cause changes to the optic nerve, including loss of vision and potential blindness. 





The goal of this thesis is to perform a meta-analysis of existing studies to consolidate 
existing data and better understand the relationship between OSA and several eye 
diseases including, Diabetic Retinopathy (DR), Diabetic Macular Edema (DME), Retinal 
Vein Occlusions (RVO), Central Serous Chorioretinopathy (CSCR), Age-related Macular 
Degeneration (AMD), Non-Arteritic Ischemic Optic Neuropathy (NAION), and 




























The meta-analysis for each topic was directed according to the Meta-Analysis of 
Observational Studies in Epidemiology (MOOSE) and Preferred Reporting Items for 
Systematic Review and Meta-Analysis (PRISMA) guidelines for transparency and 
credible reporting (Stroup 2000). For each section of the meta-analysis, Medical Subject 
Headings (MeSH) terms were used to perform the search in multiple databases accessed 
through PubMed, Web of Science, Scopus and EMBASE. MeSH searches for each 
section are included in Table 1. Additional methods for obtaining studies included hand-
searching citations found in included papers and meta-analyses that have previously been 
performed. 
Section of Meta-Analyses MeSH Term 
Diabetic Retinopathy “Diabetic Retinopathy”, “OSA”, “Sleep Apnea 
Syndromes”, “Sleep Disordered Breathing” 
Diabetic Macular Edema/ 
Central Macular Thickness 
“Diabetic Macular Edema”, “Macular Edema”, 
“Edema”, “Macular Thickness” “OSA”, “Sleep Apnea 
Syndromes” 
Retinal Vein Occlusion “Retinal Vein Occlusion”, “Branch Retinal Vein 
Occlusion”, “Central Retinal Vein Occlusion”, “OSA”, 
“Sleep Apnea Syndromes” 




“Macular Degeneration”, “Macular Degeneration, Age-
Related” “OSA”, “Sleep Apnea Syndromes”, “Sleep 
Wake Disorders”, “Dyssomnias”  
Non-Arteritic Ischemic Optic 
Neuropathy 
“Optic Neuropathy, ischemic”, “Optic Neuropathy”, 
“Anterior Optic Neuropathy” “OSA”, “Sleep Apnea 
Syndromes”, “Dyssomnias”  
Glaucoma “Glaucoma”, “Glaucoma, open angle”, “Glaucoma, 
normal tension”, “OSA”, “Sleep Apnea Syndromes” 






To qualify for analysis, studies must 1) include sample size of both OSA and the 
condition in question, 2) include patients in both the condition and non-condition group 
3) specify that both the condition in question and OSA are being studied, 4) be 
observational research (prospective or retrospective), 5) have a sample size greater than 
10. There was no restriction placed on journal, language or country of origin of the 




Studies were initially screened by one student with the assistance from a librarian, then 
passed on to a research team consisting of six students, one research coordinator and a 
retinal ophthalmologist for further examination. Studies were chosen based on two major 
factors: data availability and research methods. First, to be selected, studies needed to 
have published the number of patients with the eye disease in question, number of 
patients with OSA and the number of patients with both the eye disease in question and 
OSA. Additionally, the overall sample size and number of controls (if used) were also 
required in order to be included in the meta-analysis. Secondly, research methods should 
be similar between the chosen studies. For prospective studies, OSA was determined by 
polysomnography, questionnaires, or portable at-home sleeping devices. Eye diseases 




Optical Coherence Tomography (OCT), fundus photographs and fluorescein angiography 
as needed. Quantities of reviewed, excluded and selected records pertaining to the meta-
analysis topic are indicated in Figure 5. Studies were split up by section and tabulated 
below. Table 2, 3, 4, 5, 6, 7 and 8 show included studies, separated by eye disease, and 
are organized with retrospective studies listed first and followed by prospective studies 









Figure 5: PRISMA Flow Chart: Breakdown of studies that were identified, screened, 
determined eligible, and then finally included or excluded in both the final quantitative 
and qualitative meta-analysis. DR = Diabetic Retinopathy, DME = Diabetic Macular 
Edema, RVO= Retinal Vein Occlusion, CSCR= Central Serous Chorioretinopathy, 
AMD= Age-Related Macular degeneration, NAION= Non-arteritic Anterior Optic 




Table 2. Diabetic Retinopathy Studies reviewed for Quantitative Meta-Analysis: DR 
= Diabetic Retinopathy, OSA= OSA 
 
 
Table 3. Diabetic Macular Edema Studies reviewed for Quantitative Meta-Analysis: 








Table 4. Retinal Vein Occlusion Studies reviewed for Quantitative Meta-Analysis: 




Table 5. Central Serous Chorioretinopathy Studies reviewed for Quantitative Meta-
Analysis: CSCR= Central Serous Chorioretinopathy, OSA = OSA, ICD= International 









Table 6. Age-Related Macular Degeneration Studies reviewed for Quantitative 
Meta-Analysis: AMD= Age-Related Macular Degeneration, OSA = OSA, ICD= 
International Classification of Diseases 
 
 
Table 7. Non-Arteritic Anterior Optic Neuropathy Studies reviewed for 
Quantitative Meta-Analysis: NAION= Non-Arteritic Anterior Optic Neuropathy, OSA 










Table 8. Glaucoma Retrospective Studies reviewed for Quantitative Meta-Analysis: 
NTG= Normal Tension Glaucoma, POAG= Primary Open Angle Glaucoma, OSA = 





Table 9. Primary Open Angle Glaucoma Specified Retrospective Studies reviewed 
for Quantitative Meta-Analysis: NTG= Normal Tension Glaucoma, POAG= Primary 













Data Extraction and Analysis 
The information for each section is included in the charts below and indicates name of 
first author, publication year, journal of publication, type of study, sample size, 
diagnostic methods and author’s conclusion. Calculations were generated using Microsoft 
Excel and The R Project for Statistical Computing. Calculations included frequencies of 
OSA in patients in the eye disease group and in the non-eye disease group. This data was 









Association between Obstructive Sleep Apnea and Diabetic Retinopathy 
After exclusion, there were seven prospective studies eligible for analysis. Table 10 
shows results of the analyzed prospective studies, indicating the frequency of OSA in the 
non-DR group compared to the frequency of OSA in the DR group. The percentage of 
non-DR patients with OSA in these studies was 46.7%, while the frequency of OSA in 
the DR group was 63.7% with p < 0.05, indicating that the difference between the non-
DR group and DR group was significant. 
 
Table 10. Prospective Diabetic Retinopathy Data: OSA frequency in non-DR patients, 

















with OSA  
% of DR 
patients with 
OSA  
Prospective  7 1689 436 842 46.7% 63.7% 
 
 
Association between Obstructive Sleep Apnea and Diabetic Macular Edema 
For the final complication, five prospective studies were included in the analyses. Table 
11 shows the percentage of OSA in patients with DME compared to non-DME patients. 
The percentage of OSA in patients without DME was 35.3%, whereas the percentage of 
OSA in patients with DME was 73.9% with p= 5.67e-05. This suggests a strong 




Table 11. Prospective Diabetic Macular Edema Data: Frequency of OSA in patients 

















with OSA  
% of DME 
patients with 
OSA  
Prospective  5 562 160 290 35.3% 73.9% 
 
 
Association between Obstructive Sleep Apnea and Retinal Vein Occlusion 
There were three prospective studies and one retrospective study included in the final 
meta-analysis. Data from this set is summarized in Table 12. The retrospective data 
shows an OSA frequency of 25%, which is in line with the general population. The 
prevalence of OSA in the general population ranges from 9-38%, this percentage may 
additionally increase with age and demographic in question (Senaratna et al. 2017). 
However, for the prospective studies, the frequency of RVO patients with OSA is higher 
than the general population (74.6%). Unfortunately, the data from these papers were not 
very extensive. There were not enough non-RVO patients to include a z-test or any type 
of statistical verification of significance. However, it is important to note that the 
prospective cohort does have an OSA prevalence higher than the general population and 
a randomized control trial should be done to determine the relationship between OSA and 







Table 12. Retrospective and Prospective Retinal Vein Occlusion Data: Frequency of 
Retinal Vein Occlusion patients with OSA. 
 
 
Association between Obstructive Sleep Apnea and Central Serous 
Chorioretinopathy 
After exclusion, there were two prospective studies and one retrospective study available 
for analyses. The prospective studies show an OSA frequency of 37.3%, which is in line 
with the general population. Whereas the retrospective data shows a frequency of 58.6%, 
which is higher than in the general population. Again, these studies were performed 
solely on CSCR patients with no controls. Therefore, any type of statistical analyses for 
significance could not be performed. Though it may be of interest to note that the 
retrospective data shows an OSA frequency higher than the general population, and the 
prospective data showing a percentage closer to the higher end of the range of OSA for 
the general population. Additionally, the authors remarked that patients developed CSCR 
upon waking, prompting them to question further the possibility of OSA as a risk factor. 
Therefore, this topic should be researched further to determine if there is an association 












% of RVO 
patients with 
OSA 
Retrospective 1 35634 52 5965 25.0% 




Table 13. Retrospective and Prospective Central Serous Chorioretinopathy Data: 
Frequency of CSCR patients with OSA.  
 
 
Association between Obstructive Sleep Apnea and Age-Related Macular 
Degeneration 
There were not enough AMD studies to perform the meta-analyses. However, there were 
two prospective studies and one retrospective study that are of interest on this topic. 
Keenan (2017) used electronic records to assemble cohorts of AMD and OSA patients 
and compared them to matched controls. The author calculated an expected number of 
704 patients to have both diagnoses, whereas the observed number was 948 patients. This 
data suggests that the risk ratio of having OSA and subsequently becoming diagnosed 
with AMD was 1.44, and the risk ratio of having AMD and subsequently being diagnosed 
with OSA was 1.24. This data calls for additional study, as many patients in the AMD 
clinic may be suffering with OSA undiagnosed.  
 
Nesmith (2014) and Schaal (2016) also looked at how untreated OSA may affect the 
progression of AMD. Nesmith assessed patients for OSA using the Berlin questionnaire 
and pooled AMD patients from a cohort already receiving Ranibizumab injections. 











% of CSCR 
patients with 
OSA 
Retrospective 1 58 29 26 58.6% 




injections again unless visual acuity declined. This group found that patients with poor-
response exudative AMD, defined as persistent fluid below the retina after 3 consecutive 
injections, had a statistically significant risk for OSA whereas less severe forms of AMD 
did not. Schaal assessed previously diagnosed OSA patients and treated complaint 
patients with CPAP, while recording injection frequency for both the treated and 
untreated groups. Average injections for the treated group was 8, whereas the untreated 
group received 16 injections. This may prove to be a helpful association, as intra-vitreous 
injections are costly, require multiple hospital visits and are painful. Therefore, a larger 
randomized control trial examining the relationship between CPAP, OSA and AMD 
should be done to confirm these results.  
 
Association between Obstructive Sleep Apnea and Non-Arteritic Anterior Ischemic 
Optic Neuropathy 
After exclusion, there were five prospective studies eligible for analyses. Table 14 shows 
the percentage of non-NAION patients with OSA compared to those with NAION. The 
percentage of non-NAION patients with OSA was 33.5%, whereas the percentage of 
NAION patients with OSA was 61.9% with p=0.105, indicating a non-significant 








Table 14. Prospective Non-Arteritic Anterior Ischemic Optic Neuropathy Data: 

















with OSA  
% of NAION 
patients with 
OSA  




Association between Obstructive Sleep Apnea and Glaucoma (Unspecified) 
Five retrospective studies were included for analyses of glaucoma. This included primary 
open angle glaucoma, normal tension glaucoma or unspecified that was unspecified. 
Table 15 shows the results of this analyses. Of the 148,422 patients with glaucoma, 
25.7% had glaucoma. Non-glaucoma patients have OSA with a frequency of 22.4%. This 
data was not statistically different (p=0.446). Additionally, there was not enough 
prospective data to determine any type of statistical relationship between OSA and 
glaucoma. For this reason, a large prospective study may be of use in the future to 
examine this relationship further.  
 
Table 15. Retrospective Glaucoma Data: Frequency of OSA in non-Glaucoma patients 




















with OSA  





Association between Obstructive Sleep Apnea and Primary Open Angle Glaucoma  
Additionally, three retrospective studies were analyzed for the association between OSA 
and POAG. Table 16 shows the results of these studies. POAG patients showed a OSA 
frequency of 25.7% compared to non-POAG patients with a frequency of 22.4%. These 
results were statistically similar (p=0.401). Therefore, a relationship between POAG and 
OSA is unlikely according to these results. However, there was not a substantial amount 
of prospective data available. In the future, a prospective approach may be helpful in 
determining if there is a relationship between these two diseases.  
 
Table 16. Retrospective Primary Open Angle Glaucoma Data: Frequency of OSA in 
non-Primary Open Angle Glaucoma patients compared to Primary Open Angle 




















with OSA  









Obstructive Sleep Apnea and Diabetic Retinopathy 
These data suggest that rates of OSA are statistically higher in the DR group than in the 
non-DR group. This confirms the conclusions stated by previous studies including Altaf 
(2017), Storgaard (2014), Zhang (2014), West (2010), Schober (2011) and Kashine 
(2009).  
 
It is important to note that even in the non-DR group, the frequency of OSA is higher 
than that of the general population. This may be due to the fact that the patients were 
recruited from hospital settings where they may have more severe symptoms than that of 
the general population. All studies analyzed were completed in a prospective manner and 
OSA was diagnosed by way of polysomnography, at-home sleep monitors or 
questionnaires. Studies that used polysomnography are of the highest quality and 
therefore present the most accurate results. However, at-home polysomnography has been 
shown to have similar results while being more convenient and cost-efficient than full-
night polysomnography at the hospital.  
 
Because OSA rates in the DR group were statistically higher, it may be beneficial for 
ophthalmologists to screen DR patients for OSA. Since OSA has been shown to worsen 
the effects of DR, it may be beneficial to additionally treat OSA patients with CPAP to 




examining the role of oxygen therapy should be explored further to help stabilize or slow 
down the progression of DR. 
 
Obstructive Sleep Apnea and Diabetic Macular Edema 
The data suggest that rates of OSA are statistically higher in the DME group than that of 
the non-DME group. This confirms the conclusions of West (2018), Altaf (2017), 
Nesmith (2014) and Unver (2009) and provides ample reason to screen DME patients for 
OSA.  
 
Interestingly, the statistical association between DME and OSA was even higher than that 
of DR and OSA. This may be because the studies looking at DR included various 
severities of DR, ranging from R1 (non-proliferative DR) to R3 (proliferative DR). 
Patients with R1 DR diagnoses may be less likely to have OSA than people that have 
DME because they are typically younger and have more controlled diabetes (Altaf 2017). 
Therefore, the stronger association between DME and OSA seems sensible as it would 
include patients with more severe DR. Because of this, a large randomized control trial 
demonstrating the differences between PDR and NPDR with respect to OSA treatment 
would be helpful.  
 
In the future, it would be interesting to see an investigatory study that examines the levels 




OSA. This would not only confirm the results of this study, but possibly provide a more 
time-efficient, cost-friendly and painless alternative to laser treatments.  
Obstructive Sleep Apnea and Retinal Vein Occlusion  
In general, there were not many studies assessing the relationship between RVO and 
OSA. However, there were three prospective studies and one retrospective study eligible 
for further examination. However, in these studies, researchers focused on the results of 
the RVO patients and did not include any controls which excluded them from any type of 
statistical comparisons. Yet, the results of these studies are worth mentioning.  
 
Patients assessed for Retinal Vein Occlusion in a prospective manner showed an 
increased rate of OSA (74.6%) than that of the general population (9-38%), whereas the 
retrospective data collected did not show this same result (25%) (Senaratna et al. 2017). 
Reasons for this may be related to methods of data collection. The retrospective study, 
Chou, was a nationwide study of Taiwanese patients with Retinal Vein Occlusion. This 
data was determined retrospectively via the Taiwan National Health Insurance Research 
Database from 1997 to 2007. One major limitation with this study was that it did not 
include specifications between different sleep apneas and because OSA diagnoses was 
determined in medical charts, OSA diagnoses methodology is unknown. Therefore, it is 
most likely that not all patients underwent PSG.  
 
Considering the prospective data and because intra-vitreal injections affect the quality of 




relationship between OSA and RVO. Providing an alternative to injections may be a life-
changing experience for the patients who usually spend a lot of time and money coming 
to the hospital to receive the injections.  
 
 
Obstructive Sleep Apnea and Central Serous Chorioretinopathy 
Data for CSCR was inconclusive and should be researched further. Because the 
retrospective data show a higher risk of OSA (58.6%) than those of the general 
population (9-38%), but the prospective data do not (37.3%), a randomized- control trial 
should be done (Senaratna et al. 2017). The studies did not have controls to allow for 
statistical analyses and therefore, only OSA frequencies are presented. Additionally, 
looking more closely upon the methods of the studies may provide explanations for the 
high association in the retrospective group compared to that of the prospective group.  
 
Leveque (2007) used the BQ to assess the risk for OSA for previous patients of CSCR. 
This was a retrospective study that identified CSCR patients using billing codes. Matched 
controls were used in this study. The limitations for this study include small sample size, 
and using the BQ to determine OSA instead of PSG. The author calls to use this study as 
a preliminary investigation and that a randomized control-trial should be used instead. 
The authors state that there might be an overrepresentation in their data and this may 





Yavas (2014) investigated the presence of sleep apnea by using PSG, the gold standard. 
Using national standards of AHI, patients were diagnosed for OSA. Consecutive CSCR 
patients were selected using diagnosis of CSCR and confirmed via fluorescein 
angiography. Possible limitations of this study are that many CSCR patients resolved 
before PSG was administered. Additionally, there was no control group as it is difficult to 
refer normal patients for PSG. Kloos (2008) used ESS to diagnose OSA. Though ESS 
and Berlin are credible questionnaires, this presents a major limitation to the study 
because AHI levels were not measured. Additionally, there may be selection bias due to 
the people that returned the surveys. 
 
Because other studies have published that there might be a link based solely on common 
risk factors between CSCR and OSA, including increased sympathetic activity, 
procoagulant factors and hormone levels associated in CSCR patients, a randomized-
control trial should be done in the future (Liew 2013). Additionally, because the authors 
state that many patients notice CSCR upon waking, it may be worth investigating the 
association with sleeping problems to possibly prevent CSCR.  
 
Obstructive Sleep Apnea and Age-Related Macular Degeneration 
There was not enough information to perform any statistical evaluation of the association 
between AMD and OSA. However, the relationship between AMD and OSA is worth 
researching as has been shown by Keenan (2017), Nesmith (2016) and Schaal (2014). 




able to decrease the amount of injections given to their patients over a period of time. The 
preliminary studies warrant larger, prospective analyses to allow for a larger discussion 
about the possibility for using oxygen therapy to treat AMD instead of monthly 
injections. Additional studies should be conducted to determine the quality of life for 
patients using injections as their primary treatment compared with the possibility for 
using an alternative, such as CPAP or oxygen therapy. Moreover, the benefit of a study 
focusing on OSA patients would be to see if oxygen therapy just stabilizes the condition 
or can reverse it at all. As for right now, ophthalmologists should screen for possible 
undiagnosed OSA in patients with AMD. This may help to slow the progression of AMD, 
as seen in the patients from the three aforementioned studies.  
 
Obstructive Sleep Apnea and Non-Arteritic Anterior Ischemic Optic Neuropathy 
OSA levels in NAION and non-NAION groups did not differ significantly. This disputes 
the results indicated by Arda (2013), Li (2007) and Mojon (2002) that their NAION had 
significantly high OSA. However, they additionally stated that their control groups had 
increased OSA levels. This may be true for several reasons, the main one being sampling 
bias. Because they are recruiting from a hospital setting, they are already sampling from 
patients with more extreme cases which may increase their risk of OSA. Additionally, 
controls were not matched which makes it difficult to compare to the general population.  
 
Potential limitations to this study may exist in the methods for determining OSA as well. 




presents a limitation to the study because some patients may have been misdiagnosed due 
to self-reporting errors and lack of comprehensive data. Researchers, additionally, were 
not blinded to which subjects had OSA or not. Arda diagnosed NAION patients for OSA 
using polysomnography and AHI measurements. One limitation for this study was that 
controls were not matched for BMI, smoking status, diabetes, hypertension or 
atherosclerosis. This may limit the extent to which the control group data is 
generalizable. Because of the cross-sectional design of the Mojon paper (2002), only a 
potential relationship between the two can be discussed, as causation was not something 
that was studied. 
 
For this reason, it is necessary to do a larger prospective analyses to assess the 
relationship between OSA and NAION. Furthermore, ophthalmologists have differing 
opinions on whether there should be any association between these diseases at all. As 
there does not seem to be a common explanation for why they could be related. 
Therefore, in the future, along with a clinical study there should be a biochemical study 
investigating  the possible reason for why these two diseases could be linked.   
 
Obstructive Sleep Apnea and Glaucoma (Unspecified) 
The glaucoma data were more controversial than those of the other studies and this could 
be for several reasons, mainly for the issues of methodology of each of the studies 
included in the meta-analyses. Of the five retrospective studies analyzed, four of them 




between OSA and Glaucoma. The outlook confirmed these data found in this meta-
analyses in that there was no statistical association between these diseases. One possible 
limitation of this study is that it includes glaucoma of all types, or glaucoma that was 
unspecified in the coding or medical charts. This may be a vague assessment to make 
because different types of glaucoma are caused by several different issues. Therefore, 
their relationship to OSA is most likely not similar across the different types. Not only is 
this study vague, but there are also several possible limitations due to the design of the 
study. Because they are retrospective analyses, there is no specification for determining if 
polysomnography was done. Therefore, determination of OSA may be left to self-reports 
or questionnaires which may cause error, due to misdiagnoses or bias. Additionally, this 
may either increase or decrease the overall number of patients that should be diagnosed 
with sleep apneas. The number of patients reported to have sleep apnea could be 
decreased because  
OSA is frequently undiagnosed or misdiagnosed. Additionally, the number of patients 
reported to have sleep apneas could be too high depending on the codes that were used to 
identify patients and also if the patients were given questionnaires as a form of 
diagnosing OSA.  
 
Obstructive Sleep Apnea and Primary Open Angle Glaucoma  
The POAG data demonstrated that the overall rate of OSA for the non-POAG group was 
similar to the POAG group. This information confirms the results of two of the three 




analyzed were retrospective in design which would cause a few errors due to sampling or 
undiagnosed OSA. The OSA rate of non-POAG patients was 22.4%, whereas the rate for 
POAG patients was slightly higher at 25.7%. These rates are well within the range of 
normal, 9-38% (Senaratna et al. 2017). There is no reason to believe that POAG is 
associated with OSA. However, data from similar studies indicate that there may be an 
association with NTG (Hashim et al. 2014). Therefore, there should be more 
observational studies conducted on the relationship between OSA and various forms of 
glaucoma to examine their potential relationships.  
 
Conclusions  
The data from this meta-analyses calls for further study of the association between 
Obstructive Sleep Apnea (OSA) and Retinal Vein Occlusion (RVO), Age-related 
Macular Degeneration (AMD), Central Serous Chorioretinopathies (CSCR) and 
Glaucoma. This meta-analyses supports previously reported data that there is a statistical 
association between Obstructive Sleep Apnea and Diabetic Retinopathies (DR) and 
Diabetic Macular Edema (DME) (West (2018), Altaf (2017), Storgaard (2014), Zhang 
(2014), Nesmith (2014), Schober (2011), Kashine (2009), and Unver (2009)). Therefore, 
there should be further studies to investigate the effectiveness of treating these patients 
with continuous positive airway pressure therapy (CPAP) or oxygen therapy to stabilize 
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